Alumis (ALMS) Other Accumulated Expenses (2023 - 2025)
Alumis (ALMS) reported Other Accumulated Expenses of $22.3 million for Q4 2025, up 14015.82% year-over-year from N/an in Q4 2024, and up 35301.59% on a QoQ basis from $63000.0 in Q3 2025.
Alumis (ALMS) has 3 years of Other Accumulated Expenses data on file, last reported at $22.3 million in Q4 2025.
- Quarterly Other Accumulated Expenses rose 14015.82% year-over-year to $22.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.3 million (up 14015.82% YoY) and the FY2025 annual result came in at $22.3 million, up 14015.82% from the prior year.
- Other Accumulated Expenses climbed to $22.3 million in Q4 2025 per ALMS's latest filing, from $63000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $22.8 million in Q2 2025 and bottomed at $63000.0 in Q3 2025.
- The 3-year median for Other Accumulated Expenses is $7.6 million (2023), against an average of $9.5 million.
- The widest annual swing landed in 2024, when Other Accumulated Expenses tumbled 97.77%; it then surged 14015.82% in 2025.
- Tracing ALMS's Other Accumulated Expenses over 3 years: stood at $7.1 million in 2023, then plunged by 97.77% to $158000.0 in 2024, then surged by 14015.82% to $22.3 million in 2025.
- Per Business Quant, the three latest ALMS Other Accumulated Expenses figures stand at $22.3 million (Q4 2025), $63000.0 (Q3 2025), and $22.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Alumis | 1.84 Bn | 1.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.30 Mn |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 22.81 Mn |
| Mar 31, 2025 | 15.73 Mn |
| Dec 31, 2024 | 158,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 8.12 Mn |
| Dec 31, 2023 | 7.09 Mn |